等待开盘 02-04 09:30:00 美东时间
+2.170
+5.14%
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
Keybanc analyst Philip Gibbs maintains Worthington Steel (NYSE:WS) with a Overweight and raises the price target from $41 to $47.
01-23 21:29
Worthington Steel to acquire Kloeckner & Co for $2.4 billion, creating North America's second-largest steel service center.
01-16 18:15
Worthington Steel (NYSE:WS), today announced that it has entered into a Business Combination Agreement with Kloeckner & Co.Listed in Germany (XETR: KCO), Kloeckner & Co is a leading service center and metal
01-16 06:30
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Worthington Steel业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **2026财年第二季度核心财务数据:** - 净销售额:8.719亿美元 - 调整后EBITDA:4,830万美元 - GAAP净利润:1,880万美元(每股0.37美元) - 调整后每股收益:0.38美元 - 调整后EBIT:2,660万美元 - 经营现金流:9,900万美元 - 自由现金流:7,500万美元 - 资本支出:2,500万美元 - 季末现金:9,000万美元 - 净债务:9,200万美元 ## 2. 财务指标变化 **同比变化情况:**
2025-12-19 12:14
Worthington Steel (NYSE:WS) reported quarterly earnings of $0.38 per share which missed the analyst consensus estimate of $0.39 by 2.56 percent. This is a 100 percent increase over earnings of $0.19 per share from the
2025-12-18 05:11
Companies Reporting Before The Bell • 111 (NASDAQ:YI) is estimated to report ea...
2025-12-17 19:11
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
2025-12-17 10:46
Keybanc analyst Philip Gibbs maintains Worthington Steel (NYSE:WS) with a Overweight and raises the price target from $36 to $39.
2025-12-16 21:35
Investors are prepping for this week's earnings reports which include homebuilders, several apparel companies and a big tech company.
2025-12-15 23:54